Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 33, Issue 4, Pages 814-824
Publisher
Wiley
Online
2017-09-30
DOI
10.1111/jgh.14007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of the Clinicopathological Characteristics of Gastric Cancer in Extremely Old Patients
- (2017) Il Woong Sohn et al. Cancer Research and Treatment
- The impact of comorbidity on cancer and its treatment
- (2016) Diana Sarfati et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemotherapy in Elderly Patients with Gastric Cancer
- (2016) Hyeong Su Kim et al. Journal of Cancer
- FDA Approval Summary: Ramucirumab for Gastric Cancer
- (2015) S. J. Casak et al. CLINICAL CANCER RESEARCH
- Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP
- (2015) Ann A Lazar et al. Clinical Trials
- RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy—An age-group analysis.
- (2015) Kei Muro et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab: First Global Approval
- (2014) Raewyn M. Poole et al. DRUGS
- Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years
- (2014) Hee Jung Park et al. Gastric Cancer
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Characteristics and prognosis of gastric cancer in young patients
- (2013) TARO ISOBE et al. ONCOLOGY REPORTS
- Modeling the Rate of Senescence: Can Estimated Biological Age Predict Mortality More Accurately Than Chronological Age?
- (2012) M. E. Levine JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Gastric Adenocarcinoma in Young Patients: a Population-Based Appraisal
- (2011) Waddah B. Al-Refaie et al. ANNALS OF SURGICAL ONCOLOGY
- YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
- (2011) Shu Tian et al. CANCER SCIENCE
- Retrospective analysis of prognostic outcome of gastric cancer in young patients
- (2011) Rieko Nakamura et al. International Journal of Clinical Oncology
- Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
- (2010) William F. Anderson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
- (2010) Jennifer L. Spratlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China
- (2010) Miao-zhen Qiu et al. TUMOR BIOLOGY
- Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea
- (2010) Hye Won Chung WORLD JOURNAL OF GASTROENTEROLOGY
- Clinicopathological aspects and prognostic value with respect to age: An analysis of 3,362 consecutive gastric cancer patients
- (2009) Jun Chul Park et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinicopathologic Characteristics and Prognosis for Young Gastric Adenocarcinoma Patients after Curative Resection
- (2008) Ji Fu Lai et al. ANNALS OF SURGICAL ONCOLOGY
- Incidence and Long-term Outcome of Young Patients With Gastric Carcinoma According to Sex
- (2008) Jong-Han Kim ARCHIVES OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More